UniXell Biotechnology has received U.S. FDA Investigational New Drug clearance for UX-DA003, its allogeneic induced plur...
The Australian government is providing more than $15 million to Monash University and Atisama Therapeutics to revolution...
Despite causing millions of serious infections and hundreds of thousands of deaths each year, fungal diseases continue t...
During BIO 2026 in San Diego, BioSpectrum Asia spoke with Kurt Imhof, Senior Vice President, Policy & Public Affairs...
As obesity treatment enters a new phase of innovation, the industry is increasingly looking beyond GLP-1 therapies to ad...
As obesity treatment evolves beyond weight loss toward comprehensive cardiometabolic disease management, pharmaceutical ...
China-based Abbisko Therapeutics has entered into a strategic research collaboration and licence agreement with US-based...
Few therapeutic areas have witnessed the level of progress achieved in HIV over the past three decades...
Artificial intelligence has long promised to transform healthcare, yet widespread adoption has often been hindered by ch...
Lys Therapeutics has raised more than €25 million since its founding in 2021 to advance LYS241, its lead neurovascu...
Phanes Therapeutics has completed enrolment in its Phase II study of spevatamig in combination with standard-of-care che...
AnHorn Medicines has received U.S. FDA Investigational New Drug clearance and Taiwan Center for Drug Evaluation Index Ca...
Autoimmune and inflammatory diseases frequently affect the eye, yet ophthalmology has largely remained on the sidelines ...
The search for safer and more effective pain therapies remains one of medicine's most pressing challenges. Despite advan...
As artificial intelligence reshapes the future of genomic medicine, WhiteLab Genomics is positioning itself at t...
Artificial intelligence is rapidly transforming biologics discovery, but the industry's focus is shifting from generatin...
Despite decades of advances in oncology, many solid tumours remain difficult to treat effectively without exposing patie...
Cancer drug discovery is entering a more disciplined era. Investors, partners, and clinicians are increasingly focused o...
Cancer immunotherapy is entering a new phase—one that extends beyond targeting individual tumour cells and towards...
As biologics and cell and gene therapies continue to advance, manufacturing infrastructure is emerging as a critical det...
As cell and gene therapies move from clinical promise to commercial reality, the industry is increasingly recognising th...
Cell and gene therapies have transformed the treatment landscape for complex diseases, yet scaling these innovations bey...
Researchers at the University of Otago, New Zealand are investigating a blood-based prostate cancer detection approach u...
Sonire Therapeutics has received approximately $13 million in non-dilutive funding through Japan’s NEDO Deep-Tech ...
South Korea-based LG AI Research has signed a master agreement with D&D Pharmatech for a joint next-generation oral ...
